CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Mymetics Corporation Company Snapshot
Mymetics Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mymetics with three other companies in this sector in the United States: Asterias Biotherapeutics Inc (2015 sales of $3.58 million of which 100% was Regenerative Medicine), Fate Therapeutics Inc ($2.43 million of which 100% was Biopharmaceuticals), and Protalix Biotherapeutics Inc ($4.36 million of which 100% was Biotherapeutic Products).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Mymetics Corporation
  Stock Performance Chart for Mymetics Corporation
 
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2017): .02
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks 22.2%  
4 Weeks 69.2%   52 Weeks 10.0%  
 
Mymetics Corporation Key Data:
  Ticker: MYMX Country: Switzerland
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 3,478,704
(Year Ending Jan 2016).
Employees: 8
  Currency: U.S. Dollars Market Cap: 6,682,668
  Fiscal Yr Ends: December Shares Outstanding: 303,757,622
  Share Type: Common Closely Held Shares: 166,772,932
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.